Category:

...the new crop of pharmacy students nationwide will need much more than an introduction to rudimentary science courses, thanks to the notable progress that the pharmacy industry has made in advancing the clinical role of pharmacists. The pandemic also has elevated pharmacists’ roles and allowed them to assume expanded responsibilities...Many pharmacy schools are stepping up to the plate with new courses and electives, as well as honing some of their existing courses, to ensure that their students are well prepared to meet the myriad challenges that they will face as newly minted pharmacists...READ MORE

...“Why Pharmacies Overcharge,” an entertaining and provocative video on the pharmacy industry and its generic prescription pricing...It’s definitely worth your time...The video covers the history of pharmacy, from the “Soda Fountain Era” to “Lick, Stick, and Pour” to the rise of PBMs and GoodRx...READ MORE

Preventing medication errors is an essential component of caring for patients and must be a core mission of every pharmacy. For medication error–prevention efforts to be effective, they must be a priority...The information in the tables of this review summarizes many of the significant error-prevention strategies recommended in the ISMP Medication Safety Alert! Acute Care newsletter from January through December 2020...READ MORE

Table 1. Safety Issues Related to Labeling, Packaging, and Nomenclature
Auxiliary label obscures critical reconstitution information on label of REVATIO (sildenafil; Pfizer) oral suspension carton

Table 2. Safety Issues Associated With Order Communication and Documentation
Confusion between LYUMJEV and HUMALOG (both insulin lispro by Lilly), which have different onsets of action

Table 3. Problems Involving Drug Information, Patient Information, Patient Education, and Staff Education
Administer adenosine rapidly for cardioversion

Table 4. Safety Issues Related to Medical Devices and Equipment
Bypassing soft low-dose alerts for subtherapeutic heparin infusions

Table 5. Other Discussion Items
Differences between human error, at-risk behavior, and reckless behavior

Table 6. ISMP’s Targeted Medication Safety Best Practices for Hospitals
FDA removes syringe administration from vinCRIStine labeling

Starting Friday, November 27, 2020, pharmacies must buy and sell only products with a required “product identifier” on their packages. This requirement is part of the phased-in implementation of the Drug Supply Chain Security Act of 2013, also known as the “track-and-trace” law. By Friday, dispensers should be familiar with this requirement and know what to do if a product identifier is not on the package when they receive products that require it. The product identifier is on most drug packages in both human-readable format and on a machine-readable 2D data matrix barcode...“The challenge for dispensers is that not all drug product packages are required to have a product identifier, and there is no central database to check if a product should have one,”...READ MORE

As the world enters the third year of the COVID-19 pandemic, the healthcare industry faces a variety of ongoing challenges and shifts in delivery of care, according to a new 2022 predictions report...They identified five key predictions for the coming year:

1. Health disparities will negatively impact rural Americans twice as much as urban Americans

2. Labor shortages will double the medication error rate among providers

3. Healthcare will no longer be considered a trusted industry as misinformation and cyberattacks continue

4. Sixty percent of virtual care visits will be related to mental health

5. The number of hospital-at-home providers will triple...READ MORE

Other recommendations include boosting local production, promoting research and development, and creating robust quality management maturity...The White House and several federal agencies...released a series of policy recommendations for addressing the vulnerabilities in U.S. pharmaceutical supply chains...The review came in response to an executive order signed by President Joe Biden...that directed the government to identify risks, address vulnerabilities and develop a strategy to promote supply chain resilience throughout sectors...READ MORE

• Safety Issues Related to Labeling, Packaging, and Nomenclature
• Safety Issues Associated With Order Communication and Documentation
• Problems Involving Drug Information, Patient Information, Patient Education, and Staff Education
• Safety Issues Related to Medical Devices and Equipment
• Other Discussion Items
• SMP’s Targeted Medication Safety Best Practices for Hospitals...READ MORE

The NCPA Digest...found that the industry in 2020 represented 34% of all retail pharmacies in the United States and a $67.1 billion marketplace...

...total number of independent pharmacies, which is 19,397 as of June 2021. The store count...of 21,683 in 2019.

Ninety-five percent of independent community pharmacy...identified their primary pharmacy operation as retail pharmacy. Nearly 5% identified as compounding, long-term care, or specialty.

Between 2014-20, the generic dispense rate increased from 80% to 86%.

Seventy-four percent of community pharmacies serve population areas of 50,000 or fewer.

3,483 pharmacies are participating in the CPESN USA national network of clinically integrated pharmacies.

...2020, average prescription volume was 57,648 per store, a very slight increase from the 57,414 prescriptions dispensed in 2019.

Government programs continue to grow in importance, with 55% of total prescriptions covered by the Medicare Part D and Medicaid programs.

The top four point-of-care services provided are SARS-CoV-2 diagnostic testing (32%), blood glucose (24%), influenza (24%), and rapid strep (22%)...READ MORE

Lawmakers behind the Improving Seniors’ Timely Access to Care Act...not only requires electronic prior authorization for MA plans, but also requires the Department of Health and Human Services to create a process for faster decisions on items and services that commonly get approved...While the bill only applies to MA plans, lawmakers hope to eventually tackle more types of insurance such as commercial plans...READ MORE

For our 2020 survey, we received 1037 responses from pharmacists. This year undoubtedly posed new challenges for pharmacy amid the coronavirus disease 2019 (COVID-19) pandemic, and our findings underscore the effects...Compensation...pharmacists are still largely making close to what they made in previous years...41% said they received additional income in 2020. The highest earners reported an extra $15,000 or more on average, but most respondents reported between $1001 to $5000 in extra income...Stress and Workload...Management pressure, high work volume, endless amounts of paperwork––all of these are part of a pharmacist’s job...Compounded with the ongoing pandemic and high patient demand, it is no surprise that pharmacists are generally feeling more overwhelmed this year...survey results showed that pharmacists reported higher stress levels and increased workloads in 2020 compared with previous years. Seventy-three percent indicated increased stress levels in 2020 compared with 61% in 2019...READ MORE